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56Vascular control for a forequarter amputation of a
massive fungating humeral osteosarcoma
Aleksandra Policha, MD,a Melissa Baldwin, MD,b Timothy Rapp, MD,c Dean Smith, MD,d
Vishal Thanik, MD,e and Mikel Sadek, MD,a New York, NY
Forequarter amputation is a radical operation performed for treatment of malignant neoplasms of the shoulder girdle not
amenable to limb salvage. Traditional approaches involve bone and soft tissue resection, followed by ligation of the
axillary vessels. We describe a technique to minimize blood loss whereby control of the subclavian vessels is performed
before amputation of a large tumor associated with extensive venous congestion. A 34-year-old man presented with
proximal humeral osteosarcoma. Surgery involved claviculectomy to facilitate vascular control of the subclavian vessels,
followed by guillotine amputation at the proximal upper arm level and completion of the amputation as conventionally
described. (J Vasc Surg Cases 2016;2:56-8.)Forequarter amputation (FQA), or interscapulothora-
cic resection, is an extensive surgical procedure that entails
removal of the entire upper extremity and shoulder girdle,
including the scapula and clavicle. It was originally per-
formed in the 19th century for traumatic upper extremity
injuries.1,2 Currently, indications for FQA include pallia-
tion or treatment of malignant neoplasms of the shoulder
girdle or surrounding soft tissues that invade the gleno-
humeral joint, brachial plexus, or axillary vessels (primarily
bone or soft tissue sarcomas) as well as recurrent sarcomas
that have failed limb-sparing surgery. FQA is rarely indi-
cated today as 90% to 95% of patients with bone and soft
tissue sarcomas of the shoulder girdle can be successfully
treated with limb-sparing surgery and adjuvant therapy.3
Although FQA is primarily performed by orthopedic
surgeons, a multidisciplinary approach, including vascular
surgeons, may be necessary if early vascular control is
needed to prevent exsanguination with a massive tumor
and signiﬁcant venous congestion. Herein, we describe
the operative management of a young man who presented
with a large osteosarcoma of the proximal humerus not
amenable to limb salvage, with emphasis on the steps taken
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CASE REPORT
A 34-year-old man presented to the emergency department
with a large, infected mass of the proximal right upper extremity.
One year before the current presentation, he was evaluated at an
outside institution, where a biopsy had demonstrated high-grade
humeral osteosarcoma. Surgery was recommended at the time,
but the patient refused treatment and traveled to his native
Honduras to seek alternative therapy. On presentation, he was
febrile to 102F and tachycardic. On examination, the proximal
right upper extremity was largely replaced by fungating tumor
draining purulent ﬂuid from an abscess cavity with signiﬁcant
edema extending along the entire right side of the chest. Labora-
tory ﬁndings included a hematocrit of 18.9% and a white blood cell
count of 13.6/mL. Imaging studies demonstrated a destructive
mass replacing much of the proximal humerus, with involvement
of the glenohumeral joint and compression of the venous vascula-
ture (Fig 1). He was started on antibiotics and resuscitated as a
metastatic workup was pursued, which proved to be negative.
The oncology service recommended FQA with adjuvant ther-
apy for curative intent, as the resection margins, including the
chest wall, paraspinal muscles, thoracic outlet, and posterior cervi-
cal triangle, appeared free of disease by imaging. Neoadjuvant ther-
apy was not an option as the patient was in septic shock and in
need of immediate operative intervention to control the source
of infection. A multidisciplinary operative intervention was planned
with vascular surgery, orthopedics, and plastic surgery. Because of
the size of the lesion and degree of venous congestion (Fig 2), the
decision was made that proximal vascular control of the subclavian
vessels was necessary before any resection and that guillotine
amputation and rapid removal of the massively edematous arm
would be required to control the source of venous congestion. A
claviculectomy is routinely performed as part of an FQA. Perform-
ing this maneuver early in the operation afforded better exposure
to the subclavian vessels and served to minimize bleeding. An
attempt to expose the axillary vessels would have required dissec-
tion through a very congested chest wall and would have resulted
in signiﬁcantly more hemorrhage. An alternative method to
Fig 1. Plain ﬁlm illustrating a large destructive osseous lesion
extending from the proximal humeral diaphysis to the humeral
head and glenoid, with marked associated aggressive periosteal
reaction as well as areas of pathologic fracture.
Fig 2. Intraoperative picture demonstrating the massive size of
the affected right upper extremity and the normal left upper
extremity.
Fig 3. Guillotine amputation of the right upper extremity at the
shoulder level.
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lize or to plug the subclavian artery through an endovascular
approach; however, this was not done, given the relatively simple
and expeditious access to the subclavian vessels that removal of
the clavicle afforded. With the patient positioned supine, a paracla-
vicular incision was made, through which a claviculectomy was
performed, and the subclavian vessels were exposed and encircled
with Silastic loops. Proximal subclavian artery control was obtained
central to the dorsal scapular artery, which served to minimize
bleeding during the division of the levator scapulae and rhomboid
muscles. The limb could not be exsanguinated of venous blood
with an Esmarch bandage because of the grossly infected nature
of the tumor. A meticulous dissection was attempted, and the
blood loss was signiﬁcant immediately after skin incision. To mini-
mize further potential blood loss, the subclavian artery was
clamped and a guillotine amputation was performed at shoulder
level (Fig 3). The subclavian vein was then occluded with a vesselloop, and the wound was rapidly packed. After removal of the bulk
of the specimen, soft tissue bleeding was mostly controlled. The
axillary vessels were then ligated, as were the nerves of the brachial
plexus, to prevent neuroma formation. The remainder of the FQA
was completed in standard fashion, with curative intent, and the
wound was closed primarily over drains.
The patient received 14 units of packed red blood cells, 8 units
of plasma, 2 units of platelets, and 3 liters of crystalloid. Much of
this was secondary to the signiﬁcant resuscitation he required for
treatment of sepsis. He had an uncomplicated postoperative course
and was discharged to a rehabilitation facility on postoperative
day 5. Surgical pathology demonstrated high-grade osteosarcoma
with positive margins. At 6-month follow-up, he was tolerating
adjuvant chemoradiation therapy.
DISCUSSION
Advancements in chemoradiation protocols and surgi-
cal technique have made limb-sparing surgery the standard
of care for most cases of upper extremity sarcomas. Today,
FQA is reserved for very large proximal humeral or scapular
tumors associated with fractures, hemorrhage, infection,
neurovascular involvement, failed resection, or tumor pro-
gression despite neoadjuvant therapy.3 Although the peri-
operative mortality associated with FQA is low, reported
as 3% in one study, the overall prognosis of the patients
undergoing this procedure is dismal because of the aggres-
sive nature of the malignant neoplasms for which FQA is
performed.4 In a review of studies that included at least
10 patients undergoing FQA, survival beyond 5 years was
reported to be 14% to 38%. For the subset of patients un-
dergoing surgery with palliative intent, the median overall
survival was 5 to 21 months.5 A single-center retrospective
review reported a similarly poor median overall survival of
9.8 months.4
The original anterior and posterior approaches to FQA
were described by Berger and Littlewood, respectively.6
Today, the most common technique begins with the pa-
tient in a semilateral position, and the majority of the
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utilitarian incision is used, and the pectoralis major muscle
is detached from the clavicle. A clavicular osteotomy is per-
formed to allow control of the subclavian vessels. A poste-
rior incision is then made to detach the scapula from the
rhomboid, trapezius, levator scapulae, and latissimus dorsi
muscles. The scapula is then resected from the chest wall,
and an axillary incision is made to connect the anterior
and posterior incisions. The subclavian vessels and brachial
plexus are ligated, and the forequarter is removed.3,7 An
excellent illustration of this operative technique is provided
by Malawar and Sugerbaker.3 A posterior approach is
seldom used, particularly in the setting of large tumors
that displace the subclavian vessels and make these struc-
tures vulnerable to injury.
There are additional variations in the surgical technique
for FQA, including the timing of vascular control. The
patient in this report presented with massive edema of
the upper extremity and chest. Therefore, it was decided
that early proximal control of inﬂow would be necessary
to limit blood loss. Options for this included claviculec-
tomy with control of the subclavian vessels and mini-
median sternotomy with brachiocephalic control. The deci-
sion was made to proceed with the former, less morbid
procedure. Before occlusion of the subclavian vein, a guil-
lotine amputation was performed to minimize venous hy-
pertension and bleeding from raw surfaces during
resection. Ultimately, the axillary vessels were ligated at
the amputation site, and the subclavian vessels were
unclamped. The remainder of the operation proceeded
with improved hemostasis.CONCLUSIONS
Advancements in operative technique and adjuvant ther-
apy have made limb-sparing surgery the standard of care for
most patients with advanced-stage proximal upper extremity
sarcomas. Nonetheless, FQA is still indicated in select cases,
and vascular surgeons should be familiar with this procedure.
In cases of large tumors with venous congestion and associ-
ated sepsis, we advocate for early subclavian vessel control
and guillotine amputation of the congested extremity,
followed by formal vessel ligation and forequarter resection.
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